Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors despite daily gains
The stock's rise snapped a three-day losing streak.
BD Announces Intent To Separate Biosciences And Diagnostic Solutions Business To Enhance Focus, Drive Growth And Unlock Value
Our BD 2025 strategy has transformed the company into a faster-growing, more profitable organization positioned at the forefront of long-term growth ...
IFLR5h
This week’s people moves: Weil, Broadfield, Fieldfisher and more
Watkins brings more than 27 years of experience to Fieldfisher, with a focus on cross-border mergers and acquisitions, PE ...
MassDevice2h
BD announces intent to sell Life Sciences business, beats Street in Q1
BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences business.
TMCnet4h
Stax Appoints Adam Thorpe as Managing Director to Lead EMEA Healthcare Vertical and Drive Expansion in UK and European Markets
Stax LLC, a global strategy consulting firm specializing in commercial due diligence, value creation, and exit planning for ...